BFMO (biogenic Fe-Mn oxides)
CAS No. 69010-90-8
BFMO (biogenic Fe-Mn oxides) ( N,N'-Difurfuryloxamide )
产品货号. M27531 CAS No. 69010-90-8
BFMO (biogenic Fe-Mn oxides, defined as a mixture of biogenic Mn oxide (BMO) and Fe oxide) could eliminate or decrease Fe(II), Mn(II), and As(III&V) species simultaneously.
纯度: >98% (HPLC)
规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥1855 | 有现货 |
|
10MG | ¥3102 | 有现货 |
|
25MG | ¥5208 | 有现货 |
|
50MG | ¥7412 | 有现货 |
|
100MG | ¥10125 | 有现货 |
|
500MG | ¥20088 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称BFMO (biogenic Fe-Mn oxides)
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述BFMO (biogenic Fe-Mn oxides, defined as a mixture of biogenic Mn oxide (BMO) and Fe oxide) could eliminate or decrease Fe(II), Mn(II), and As(III&V) species simultaneously.
-
产品描述BFMO (biogenic Fe-Mn oxides, defined as a mixture of biogenic Mn oxide (BMO) and Fe oxide) could eliminate or decrease Fe(II), Mn(II), and As(III&V) species simultaneously. Moreover, BFMO can be used for As removal from water containing high concentrations of Fe(II) and Mn(II).
-
同义词N,N'-Difurfuryloxamide
-
通路Others
-
靶点Other Targets
-
受体β2-adrenergic receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number69010-90-8
-
分子量248.2
-
分子式C12H12N2O4
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESO=C(C(NCc1ccco1)=O)NCc1ccco1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
Loreclezole
Loreclezole is a selective GABAA receptor modulator and acts as a positive allosteric modulator of β2 or β3-subunit-containing receptors.
-
Falcarindiol
Falcarindiol is a potential new anticancer agent that exerts its activity through inducing ER stress and apoptosis.
-
CALP1
Cell-permeable calmodulin (CaM) agonist that binds to the EF-hand/Ca2+-binding site; produces CaM-dependent activation of phosphodiesterase. Also binds to cytoplasmic sites on other Ca2+ channels, including NMDA and HIV-1 gp120-activated channels, inhibiting Ca2+-mediated cytotoxicity and apoptosis (IC50 = 52 μM). Shown to protect pancreatic acinar cells from gossypol induced necrosis. Inhibits VLA-5-mediated adhesion of mast cells to fibronectin in vitro and attenuates inflammatory cell influx in guinea pig lung in vivo.